Alan Mast Knows Firsthand How Far Blood Research Has Come
Versiti Blood Research Institute posted on LinkedIn:
”Alan Mast, MD, PhD, knows firsthand how far blood research has come. When his daughter developed a blood clot in her brain, he reflected on the power of progress: “50 years ago, she would have only had a 70% chance of survival. 30 years ago, she would have been in the hospital for two weeks, receiving intravenous solutions. Now she’s able to be treated as an outpatient with a pill.”
Today, Dr. Mast’s lab investigates Tissue Factor Pathway Inhibitor (TFPI), a protein that helps prevent clot formation. By studying how TFPI interacts with blood vessels and platelets, his team is advancing understanding of bleeding and clotting disorders—and helping bring precision medicine into vascular diagnostics.
Read the case study to learn more.”
Keep up with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis